Supply Chain

FDA Commissioner Scott Gottlieb, MD, outlined the agency's efforts to reduce drug prices, reflected on 2017's medical innovations and drafted goals for policy in 2018 in a blog post published Jan. 9.

The American Red Cross is experiencing a critical shortage of blood donations after a winter storm ripped through much of the Northeast last week, forcing the organization to cancel numerous blood drives, reports the Finger Lakes Times.

High drug prices were a hot topic of discussion at HHS secretary nominee Alex Azar's Senate confirmation hearing Tuesday, reports USA Today.

GlaxoSmithKline replaced roughly 50 of the 125 top managers, including the company's former CEO, since Emma Walmsley began in her role as head of the company last April. She said the restructuring represents an effort to increase diversity within the team…

Mylan confirmed Monday that it will complete a $1 billion share repurchase plan, which was previously approved by its board of directors.

Maryland lawmakers want to eliminate a "gag rule" that forbids pharmacists from sharing better deals on prescription drugs with patients, reports the Washington Examiner.

Cerebrotech Medical Systems on Jan. 4 earned FDA clearance for the Cerebrotech Visor, a diagnostic device for patients undergoing neurological assessment.

Here are six drug and medical device companies that made headlines in the past week.

Caring Voice Coalition, one of the largest patient assistance charities in the nation, will not offer financial aid this year, reports Reuters.

During Alex Azar's tenure in multiple leadership roles at Eli Lilly, the drug company extended the patent for Cialis by testing the best-selling erectile dysfunction drug on children, according to Politico.